Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
D171G
-
the mutation leads to an 8-10fold increase in polyhydroxyalkanoate content in the T1 transgenic Arabidopsis thaliana, compared to plants harboring the wild type enzyme gene
D459V/A513C
-
the mutant shows a 1.1fold increase in specific enzyme activity and polyhydroxyalkanoate accumulation increases by 26% as compared with the wild type enzyme
F326I/F518I
-
the mutant shows a 1.06fold increase in specific enzyme activity and polyhydroxyalkanoate accumulation increases by 11% as compared with the wild type enzyme
F362I/F518I
-
the double mutation of Phe362Ile and Phe518Ile of PhaCAc causes a 6% increment in the specific synthase activity and an 11% increment of PHA accumulation compared to wild-type synthase
N149S
-
the mutation leads to an 8-10fold increase in polyhydroxyalkanoate content in the T1 transgenic Arabidopsis thaliana, compared to plants harboring the wild type enzyme gene
S103C/F518I
-
the mutant shows a decrease in specific enzyme activity (to 74%) and polyhydroxyalkanoate accumulation decreases by 45% as compared with the wild type enzyme
V214G
-
the mutant shows a 2.16fold increase in specific enzyme activity and polyhydroxyalkanoate accumulation increases by 7% as compared with the wild type enzyme
C130S
-
121% of wild-type activity in the initial phase of reaction, 16% of wild-type activity in tghe second phase of reaction
C149A
-
inactive mutant protein of PhaC
C149S
-
0.1% of wild-type activity in the initial phase of reaction, 0.09% of wild-type activity in tghe second phase of reaction
c149S/H331Q
-
no activity
C292A
-
mutant of PhaC with wild-type activity
D302A
-
incubation of D302A-PhaCPhaE with [14C]-hydroxybutanoyl-CoA results in detection of oligomeric HBs covalently bound to PhaC, at hydroxybutanoyl-CoA to enzyme ratios between 5 and 100
D302N
-
0.012% of wild-type activity in the initial phase of reaction, 0.29% of wild-type activity in tghe second phase of reaction
H303Q
-
0.25% of wild-type activity in the initial phase of reaction, 1.6% of wild-type activity in tghe second phase of reaction
H331Q
-
51% of wild-type activity in the initial phase of reaction, 73% of wild-type activity in tghe second phase of reaction
A372_C382del
-
no detectable activity
A510S
mutant is able to synthesize a lactate-3-hydroxybutanoate copolymer containing 7 mol% lactate and with a averge molecular weight of 320000 Da. The polymer contains a high ratio of an LA-LA-LA triad sequence
A510X
mutation corresponds to position 481 in the class II lactate polymerizing polyhydroxyalkanoate synthase PhaC1PsSTQK, in which Gln481Lys is essential to its lactate polymerizing activity. Among 19 A510X mutants, 15 synthesize lactate-3-hydroxybutanoate copolymers
A81E
-
in vitro activity is 108% of wild-type activity
A81G
-
in vitro activity is 99% of wild-type activity
A81M
-
in vitro activity is 101% of wild-type activity
A81P
-
in vitro activity is 105% of wild-type activity
C438G
-
no detectable activity
D281_D290del
-
no detectable activity
D480N
-
0.004% of the wild-type activity
E267K
-
40% of wild-type activity
E578_A589del
-
no detectable activity
F396L
-
about 40% of the poly(3-hydroxybutyrate) content compared to wild-type
F420A
-
poly(3-hydroxybutyrate) content is about 20% of wild-type value
F420C
-
poly(3-hydroxybutyrate) content is about 35% of wild-type value
f420D
-
poly(3-hydroxybutyrate) content is about 20% of wild-type value
F420E
-
poly(3-hydroxybutyrate) content is about 10% of wild-type value
F420G
-
poly(3-hydroxybutyrate) content is about 20% of wild-type value
F420H
-
poly(3-hydroxybutyrate) content is about 35% of wild-type value
F420I
-
poly(3-hydroxybutyrate) content is about 30% of wild-type value
F420K
-
poly(3-hydroxybutyrate) content is about 35% of wild-type value
F420L
-
poly(3-hydroxybutyrate) content is about 35% of wild-type value
F420M
-
poly(3-hydroxybutyrate) content is about 40% of wild-type value
F420N
-
poly(3-hydroxybutyrate) content is about 45% of wild-type value
F420Q
-
poly(3-hydroxybutyrate) content is about 30% of wild-type value
F420R
-
poly(3-hydroxybutyrate) content is about 30% of wild-type value
F420S
-
F420S enzyme has a significant decrease in its lag phase compared to that of the wild-type enzyme. Poly(3-hydroxybutyrate) content is about 85% of wild-type value
F420T
-
poly(3-hydroxybutyrate) content is about 35% of wild-type value
F420V
-
poly(3-hydroxybutyrate) content is about 35% of wild-type value
F420W
-
poly(3-hydroxybutyrate) content is about 25% of wild-type value
F420Y
-
poly(3-hydroxybutyrate) content is about 35% of wild-type value
G4A
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 14% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has higher molecular weights with that of the wild-type
G4C
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 24% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has higher molecular weights with that of the wild-type
G4D
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 58% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has higher molecular weights with that of the wild-type
G4D/F420S
-
mutant shows a higher poly(3-hydroxybutyrate) content and in vivo concentration of PhaCRe enzyme than the F420S mutant, the molecular weight of the poly(3-hydroxybutyrate) polymer of the double mutant is similar to that of the F420S mutant
G4E
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 58% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has higher molecular weights with that of the wild-type
G4F
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 45% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has higher molecular weights with that of the wild-type
G4H
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 56% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has higher molecular weights with that of the wild-type
G4I
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 56% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has rather similar molecular weights with that of the wild-type
G4K
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 58% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has higher molecular weights with that of the wild-type
G4L
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 2% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has higher molecular weights with that of the wild-type
G4M
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 24% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has higher molecular weights with that of the wild-type
G4N
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 57% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has higher molecular weights with that of the wild-type
G4P
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 54% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has higher molecular weights with that of the wild-type
G4Q
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 55% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has rather similar molecular weights with that of the wild-type
G4R
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 54% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has higher molecular weights with that of the wild-type
G4S
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 56% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has rather similar molecular weights with that of the wild-type
G4T
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 56% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has rather similar molecular weights with that of the wild-type
G4V
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 12% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has higher molecular weights with that of the wild-type
G4W
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 13% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has higher molecular weights with that of the wild-type
G4Y
-
poly(3-hydroxybutyrate) content of Escherichia coli harboring mutant PhaCRe is 54% of Ralstonia eutropha wild-type value. Poly(3-hydroxybutyrate) produced by mutant has higher molecular weights with that of the wild-type
H481Q
-
20% of the wild-type activity
H508Q
-
less than 0.0005% of the wild-type activity
L446K
-
15% of wild-type activity, no change in substrate specificity
N208D
-
about 40% of the poly(3-hydroxybutyrate) content compared to wild-type
T231I
-
no detectable activity
T323S
-
no detectable activity
V585_A589del
-
no detectable activity
Y445F
-
38% of wild-type activity, no change in substrate specificity
Y75E
-
in vitro activity is 137% of wild-type activity
Y75E/A81E
-
in vitro activity is 154% of wild-type activity
Y75F
-
in vitro activity is 104% of wild-type activity
Y75F/A81M
-
in vitro activity is 105% of wild-type activity
Y75G
-
in vitro activity is 110% of wild-type activity
Y75G/A81G
-
in vitro activity is 119% of wild-type activity
Y75P
-
in vitro activity is 138% of wild-type activity
Y75P/A81P
-
in vitro activity is 162% of wild-type activity
A510S
-
mutant is able to synthesize a lactate-3-hydroxybutanoate copolymer containing 7 mol% lactate and with a averge molecular weight of 320000 Da. The polymer contains a high ratio of an LA-LA-LA triad sequence
-
A510X
-
mutation corresponds to position 481 in the class II lactate polymerizing polyhydroxyalkanoate synthase PhaC1PsSTQK, in which Gln481Lys is essential to its lactate polymerizing activity. Among 19 A510X mutants, 15 synthesize lactate-3-hydroxybutanoate copolymers
-
C319A
-
site-directed mutagenesis
-
E130D/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
E130D/S325T/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
E130D/S477F/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
Q482K
site-directed mutagenesis, the mutant is very effective in synthesizing copolymers with a higher 3-hydroxyalkanoate fraction compared to wild-type
S326T
site-directed mutagenesis, the mutant is very effective in synthesizing copolymers with a higher 3-hydroxyalkanoate fraction compared to wild-type
S326T/Q482K
site-directed mutagenesis, the double mutant grown on nonanoic acid in Pseudomonas putida strain GPp104 or grown on valeric acid in Ralstonia eutropha strain PHB-4 shows a 2.5fold higher copolymer content with 3.8fold increased 3-hydroxyalkanoate fraction compared to wild-type
Q482K
-
site-directed mutagenesis, the mutant is very effective in synthesizing copolymers with a higher 3-hydroxyalkanoate fraction compared to wild-type
-
S326T
-
site-directed mutagenesis, the mutant is very effective in synthesizing copolymers with a higher 3-hydroxyalkanoate fraction compared to wild-type
-
S326T/Q482K
-
site-directed mutagenesis, the double mutant grown on nonanoic acid in Pseudomonas putida strain GPp104 or grown on valeric acid in Ralstonia eutropha strain PHB-4 shows a 2.5fold higher copolymer content with 3.8fold increased 3-hydroxyalkanoate fraction compared to wild-type
-
A547V
-
mutation increases polyhydroxyalkanoate yields
E130D/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
E130D/S325T/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
E130D/S477F/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
L484V
-
mutation remarkably enhances the monomer ratio of (R)-3-hydroxybutyrate in a polyhydroxyalkanoate accumulation experiment. Val is the most favorable amino acid for incorporating (R)-3-hydroxybutyrate unit synthesis
Q481M
-
mutation increases polyhydroxyalkanoate yields and enhances the (R)-3-hydroxyhexanoate monomer composition in the polyhydroxyalkanoate accumulation
S482G
-
mutation increases polyhydroxyalkanoate yields and enhances the (R)-3-hydroxyhexanoate monomer composition in the polyhydroxyalkanoate accumulation
A547V
-
mutation increases polyhydroxyalkanoate yields
-
L484V
-
mutation remarkably enhances the monomer ratio of (R)-3-hydroxybutyrate in a polyhydroxyalkanoate accumulation experiment. Val is the most favorable amino acid for incorporating (R)-3-hydroxybutyrate unit synthesis
-
Q481M
-
mutation increases polyhydroxyalkanoate yields and enhances the (R)-3-hydroxyhexanoate monomer composition in the polyhydroxyalkanoate accumulation
-
S482G
-
mutation increases polyhydroxyalkanoate yields and enhances the (R)-3-hydroxyhexanoate monomer composition in the polyhydroxyalkanoate accumulation
-
E130D/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
-
E130D/S325T/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
-
E130D/S477F/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
-
E130D/Q481K
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
E130D/S325T/Q481K
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
E130D/S477F/Q481K
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
E130D/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
-
E130D/S325T/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
-
E130D/S477F/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
-
E115K/S325C
-
highly enhanced synthesis of poly(3-hydroxybutyrate)
E130D
-
recombinant Escherichia coli strain JM109 harboring the E130D mutant gene accumulates 10fold higher (1.0 wt%) poly(3-hydroxybutyrate) from glucose, compared to recombinant Escherichia coli harboring the wild-type PHA synthase gene (0.1 wt%). Recombinant Escherichia coli strain LS5218 harboring the E130D PHA synthase gene grown on dodecanoate produces more poly(3-hydroxybutanoate-co-3-hydroxyalkanoate) (20 wt%) copolymer than an LS5218 strain harboring the wild-type PHA synthase gene (13 wt%). The E130D mutation also results in the production of copolymer with a slight increase in 3-hydroxybutanoate composition, compared to copolymer produced by the wild-type PHA synthase. Mutation results in the production of copolymer with a slight increase in 3-hydroxybutanoate composition, compared to copolymer produced by the wild-type PHA synthase. In vitro enzyme activities of the E130D PHA synthase toward various 3-hydroxyacyl-CoAs (4-10 carbons in length) are all higher than those of the wild-type enzyme. Mutation decreases the molecular weight of poly(3-hydroxybutyrate)
E130D/Q481M
-
the double mutant shows much higher poly(3-hydroxybutyrate) accumulation (29-34 wt%) compared to poly(3-hydroxybutyrate) accumulation in cells harboring PHA synthase with the individual mutations E130D or Q481M alone
E130D/Q481R
-
the double mutant shows much higher poly(3-hydroxybutyrate) accumulation (29-34 wt%) compared to poly(3-hydroxybutyrate) accumulation in cells harboring PHA synthase with the individual mutations E130D or Q481R alone
E130D/S325C
-
the double mutants of E130D with either the S325T or the S325C mutations exhibits strong synergistic increases in poly(3-hydroxybutyrate) content, up to 39 wt%
E130D/S325T
-
the double mutants of E130D with either the S325T or the S325C mutations exhibits strong synergistic increases in poly(3-hydroxybutyrate) content, up to 39 wt%
E130D/S325T/Q481K
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
E130D/S477F/Q481K
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
L20P/Q481R
-
highly enhanced synthesis of poly(3-hydroxybutyrate)
N16T/M292V/S325T
-
highly enhanced synthesis of poly(3-hydroxybutyrate)
N5D/Q481K
-
highly enhanced synthesis of poly(3-hydroxybutyrate)
Q481K/Q508L
-
site-directed mutagenesis, the mutant shows an altered substrate specificity shifted to short-chain acyl-CoAs, corresponding to the reaction of a type I PHA synthase, compared to the wild-type enzyme, which is more specific for medium-chain substrates as a type II PHA synthase
Q481M/Q508L
-
site-directed mutagenesis, the mutant shows an altered substrate specificity shifted to short-chain acyl-CoAs, corresponding to the reaction of a type I PHA synthase, compared to the wild-type enzyme, which is more specific for medium-chain substrates as a type II PHA synthase
Q481R/Q508L
-
site-directed mutagenesis, the mutant shows an altered substrate specificity shifted to short-chain acyl-CoAs, corresponding to the reaction of a type I PHA synthase, compared to the wild-type enzyme, which is more specific for medium-chain substrates as a type II PHA synthase
Q508L
-
site-directed mutagenesis, the mutant shows an altered substrate specificity shifted to short-chain acyl-CoAs, corresponding to the reaction of a type I PHA synthase, compared to the wild-type enzyme, which is more specific for medium-chain substrates as a type II PHA synthase
S325C
-
highly enhanced synthesis of poly(3-hydroxybutyrate)
S325C/H350T
-
highly enhanced synthesis of poly(3-hydroxybutyrate)
S325T/Q481K
-
S325T mutation decreases the molecular weight of poly(3-hydroxybutyrate). If the mutation is combined with the Q481K mutation, the enzyme can produce poly(3-hydroxybutyrate) with higher molecular weight
S325T/Q508L
-
site-directed mutagenesis, the mutant shows an altered substrate specificity shifted to short-chain acyl-CoAs, corresponding to the reaction of a type I PHA synthase, compared to the wild-type enzyme, which is more specific for medium-chain substrates as a type II PHA synthase
S477R
-
site-directed mutagenesis, the mutant shows an altered substrate specificity shifted to short-chain acyl-CoAs, corresponding to the reaction of a type I PHA synthase, compared to the wild-type enzyme, which is more specific for medium-chain substrates as a type II PHA synthase
S477R/Q508L
-
site-directed mutagenesis, the mutant shows an altered substrate specificity shifted to short-chain acyl-CoAs, corresponding to the reaction of a type I PHA synthase, compared to the wild-type enzyme, which is more specific for medium-chain substrates as a type II PHA synthase
E130D/S477R
-
the double mutant exhibits synergistic effects on both an increase in polyhydroxyalkanoate production (from 9 wt % to 27 wt %) and an alteration of substrate specificity
Q481K
in class II PhaC1Ps, the mutations Gln481Met/Lys/Arg allow the incorporation of non-native substrates, such as smaller 3-hydroxybutyrate fractions into the copolymer
Q481M
in class II PhaC1Ps, the mutations Gln481Met/Lys/Arg allow the incorporation of non-native substrates, such as smaller 3-hydroxybutyrate fractions into the copolymer
Q481R
in class II PhaC1Ps, the mutations Gln481Met/Lys/Arg allow the incorporation of non-native substrates, such as smaller 3-hydroxybutyrate fractions into the copolymer
S325C
the mutation causes a significant increase in the incorporation of short-chain-length (SCL) in the PHA synthesized
S325C/S477R
-
the double mutant exhibits synergistic effects on both an increase in polyhydroxyalkanoate production (from 9 wt % to 21 wt %) and an alteration of substrate specificity
S325T
the mutation causes a significant increase in the incorporation of short-chain-length (SCL) in the PHA synthesized
S325T/Q481K
the mutat shows significantly increased incorporation of short-chain-length (SCL) substrates in the polymer synthesized by class II PhaCs
S325T/S477R
-
the double mutant exhibits synergistic effects on both an increase in polyhydroxyalkanoate production (from 9 wt % to 17 wt %) and an alteration of substrate specificity
S477A
-
the mutation results in a shift in substrate specificity to smaller monomer units
S477F
-
the mutation results in a shift in substrate specificity to smaller monomer units
S477H
-
the mutation results in a shift in substrate specificity to smaller monomer units
S477R/Q481K
-
the double mutant exhibits synergistic effects on both a decrease in polyhydroxyalkanoate production (from 9 wt % to 1 wt %) and an alteration of substrate specificity
S477R/Q481M
-
the double mutant exhibits synergistic effects on both a decrease in polyhydroxyalkanoate production (from 9 wt % to 6 wt %) and an alteration of substrate specificity
S477R/Q481R
-
the double mutant exhibits synergistic effects on both a decrease in polyhydroxyalkanoate production (from 9 wt % to 0.2 wt %) and an alteration of substrate specificity
S477Y
-
the mutation results in a shift in substrate specificity to smaller monomer units
E130D/S325T/S477G/Q481K
-
engineered polyhydroxybutanoate synthase able to accept 2-hydroxyacyl-CoAs as substrates
-
S324T/Q480K
-
the mutant shows increased activity compared to the wild type enzyme
F518I
-
in broad-range class I PhaCAc, mutation of Phe518Ile increases the relative activity to 480% in the in vitro synthase activity assay, and 120% in the in vivo PHA accumulation
F518I
-
the mutant shows a 4.8fold increase in specific enzyme activity, whereas the corresponding mediated polyhydroxyalkanoate accumulation increases by 20%, as compared with the wild type enzyme
C130A
-
89% of wild-type activity in the initial phase of reaction, 39% of wild-type activity in tghe second phase of reaction
C130A
-
mutant of PhaC with0.04% of wild-type activity
A479S
site-directed mutagenesis, while mutant A479S-PhaCCs displays the same order as the wild-type enzyme with regard to chain length, it exhibits higher activity for both HBCoA and HVCoA and lower activity for HHxCoA compared to wild-type
A479S
the mutant shows an increased activity towards short-chain length (SCL) PHA, but a decreased activity towards medium-chain length (MCL) PHA
C319A
-
site-directed mutagenesis
C319A
-
heterodimer containing the mutated subunit has no activity
C319A
-
less than 0.0005% of the wild-type activity
E130D/S325T/S477G/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
E130D/S325T/S477G/Q481K
-
site-directed mutagenesis, the type II PHA synthase 1 is engineered to accept short-chain-length hydroxyacyl-CoAs including lactyl-CoA and 3-hydroxybutyryl-CoA as substrates and support the synthesis of P(3HB-co-LA) by site-directed mutagenesis of four sites, i.e. E130, S325, S477, and Q481
E130D/S325T/S477G/Q481K
the type II PHA synthase 1 is engineered to accept short-chain-length hydroxyacyl-CoAs including lactyl-CoA and 3-hydroxybutyryl-CoA as substrates and support the synthesis of P(3HB-co-LA) by site-directed mutagenesis of four sites, i.e. E130, S325, S477, and Q481
E130D/S325T/S477G/Q481K
-
the type II PHA synthase 1 is engineered to accept short-chain-length hydroxyacyl-CoAs including lactyl-CoA and 3-hydroxybutyryl-CoA as substrates and support the synthesis of P(3HB-co-LA) by site-directed mutagenesis of four sites, i.e. E130, S325, S477, and Q481
-
E130D/S325T/S477G/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
E130D/S325T/S477G/Q481K
-
site-directed mutagenesis, the type II PHA synthase 1 is engineered to accept short-chain-length hydroxyacyl-CoAs including lactyl-CoA and 3-hydroxybutyryl-CoA as substrates and support the synthesis of P(3HB-co-LA) by site-directed mutagenesis of four sites, i.e. E130, S325, S477, and Q481
E130D/S325T/S477G/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
-
E130D/S325T/S477G/Q481K
-
site-directed mutagenesis, the type II PHA synthase 1 is engineered to accept short-chain-length hydroxyacyl-CoAs including lactyl-CoA and 3-hydroxybutyryl-CoA as substrates and support the synthesis of P(3HB-co-LA) by site-directed mutagenesis of four sites, i.e. E130, S325, S477, and Q481
-
E130D/S325T/S477G/Q481K
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
E130D/S325T/S477G/Q481K
site-directed mutagenesis, the type II PHA synthase 1 is engineered to accept short-chain-length hydroxyacyl-CoAs including lactyl-CoA and 3-hydroxybutyryl-CoA as substrates and support the synthesis of P(3HB-co-LA) by site-directed mutagenesis of four sites, i.e. E130, S325, S477, and Q481
E130D/S325T/S477G/Q481K
-
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
-
E130D/S325T/S477G/Q481K
-
site-directed mutagenesis, the type II PHA synthase 1 is engineered to accept short-chain-length hydroxyacyl-CoAs including lactyl-CoA and 3-hydroxybutyryl-CoA as substrates and support the synthesis of P(3HB-co-LA) by site-directed mutagenesis of four sites, i.e. E130, S325, S477, and Q481
-
E130D/Q481K
-
E130D mutation decreases the molecular weight of poly(3-hydroxybutyrate). If the mutation is combined with the Q481K mutation, the enzyme can produce poly(3-hydroxybutyrate) with higher molecular weight
E130D/Q481K
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
E130D/S325T/S477G/Q481K
site-directed mutagenesis, the mutation leads to production of high molecular weights of P(3HB-co-LA)
E130D/S325T/S477G/Q481K
site-directed mutagenesis, the type II PHA synthase 1 is engineered to accept short-chain-length hydroxyacyl-CoAs including lactyl-CoA and 3-hydroxybutyryl-CoA as substrates and support the synthesis of P(3HB-co-LA) by site-directed mutagenesis of four sites, i.e. E130, S325, S477, and Q481
E130D/S325T/S477G/Q481K
-
engineered polyhydroxybutanoate synthase able to accept 2-hydroxyacyl-CoAs as substrates
Q481K
-
highly enhanced synthesis of poly(3-hydroxybutyrate)
Q481K
-
mutation decreases the molecular weight of poly(3-hydroxybutyrate)
Q481K
-
site-directed mutagenesis, the mutant shows an altered substrate specificity shifted to short-chain acyl-CoAs, corresponding to the reaction of a type I PHA synthase, compared to the wild-type enzyme, which is more specific for medium-chain substrates as a type II PHA synthase
Q481M
-
highly enhanced synthesis of poly(3-hydroxybutyrate)
Q481M
-
site-directed mutagenesis, the mutant shows an altered substrate specificity shifted to short-chain acyl-CoAs, corresponding to the reaction of a type I PHA synthase, compared to the wild-type enzyme, which is more specific for medium-chain substrates as a type II PHA synthase
Q481R
-
highly enhanced synthesis of poly(3-hydroxybutyrate)
Q481R
-
site-directed mutagenesis, the mutant shows an altered substrate specificity shifted to short-chain acyl-CoAs, corresponding to the reaction of a type I PHA synthase, compared to the wild-type enzyme, which is more specific for medium-chain substrates as a type II PHA synthase
S325T
-
highly enhanced synthesis of poly(3-hydroxybutyrate)
S325T
-
mutation decreases the molecular weight of poly(3-hydroxybutyrate)
S325T
-
site-directed mutagenesis, the mutant shows an altered substrate specificity shifted to short-chain acyl-CoAs, corresponding to the reaction of a type I PHA synthase, compared to the wild-type enzyme, which is more specific for medium-chain substrates as a type II PHA synthase
S477G
the mutant of PhaC1Ps shows enhancement in the in vitro activity with both short-chain-length (SCL) and medium-chain-length (MCL) substrates
S477G
-
the mutation greatly enhances activity toward all different sizes of substrates with carbon numbers ranging from 4 to 12
S477R
-
the mutation contributes to a shift in substrate specificity to smaller monomers containing a 3-hydroxybutyrate unit rather than to an enhancement in catalytic activity
S477R
-
the mutation results in a shift in substrate specificity to smaller monomer units
S326T/Q482K
-
the mutations increase the enzyme substrate specificity toward 3-hydroxybutyrate enhance synthase activity for more PHA production
S326T/Q482K
-
the mutations increase the enzyme substrate specificity toward 3-hydroxybutyrate enhance synthase activity for more PHA production
-
additional information
engineering of a chimeric polyhydroxyalkanoate (PHA) synthase PhaCAR is composed of N-terminal portion of Aeromonas caviae PHA synthase and C-terminal portion of Ralstonia eutropha (Cupriavidus necator) PHA synthase. PhaCAR has a unique and useful capacity to synthesize the block PHA copolymer poly(2-hydroxybutyrate-block-3-hydroxybutyrate) [P(2HB-beta-3HB)] in engineered Escherichia coli from exogenous 2HB and 3HB. Synergy of valine and threonine supplementation on poly(2-hydroxybutyrate-block-3-hydroxybutyrate) synthesis in engineered Escherichia coli expressing chimeric polyhydroxyalkanoate synthase, overview. Incorporate the amino acid-derived 2-hydroxyalkanoate (2HA) units using PhaCAR and the 2HA-CoA-supplying enzymes lactate dehydrogenase (LdhA) and CoA transferase (HadA). Cells harboring the genes for PhaCAR, LdhA, and HadA, as well as for the 3HB-CoA-supplying enzymes beta-ketothiolase and acetoacetyl-CoA reductase, are cultivated with supplementation of four hydrophobic amino acids, i.e. leucine, valine, isoleucine, and phenylalanine, in the medium. No hydrophobic amino acid-derived monomers are incorporated into the polymer, which is most likely because of the strict substrate specificity of PhaCAR, except for P(2HB-co-3HB) which is produced with Val supplementation. The copolymer is likely P(2HB-beta-3HB) based on proton nuclear magnetic resonance analysis. Dual supplementation with Thr and Val shows synergy on the 2HB fraction of the polymer. Valine supplementation promotes the 2HB synthesis likely by inhibiting the metabolism of 2-oxobutyrate into Ile and/or activating Thr dehydratase. PhaCAR spontaneously synthesizes poly(2HB-block-3-hydroxybutyrate) [P(2HB-beta-3HB)] from the mixture of 2HB and 3HB supplemented in the medium. Poly(2-hydroxybutyrate-block-3-hydroxybutyrate) [P(2HA-beta-3HB)] biosynthesis pathways from threonine in engineered Escherichia coli and proposed role of valine, overview
additional information
-
engineering of a chimeric polyhydroxyalkanoate (PHA) synthase PhaCAR is composed of N-terminal portion of Aeromonas caviae PHA synthase and C-terminal portion of Ralstonia eutropha (Cupriavidus necator) PHA synthase. PhaCAR has a unique and useful capacity to synthesize the block PHA copolymer poly(2-hydroxybutyrate-block-3-hydroxybutyrate) [P(2HB-beta-3HB)] in engineered Escherichia coli from exogenous 2HB and 3HB. Synergy of valine and threonine supplementation on poly(2-hydroxybutyrate-block-3-hydroxybutyrate) synthesis in engineered Escherichia coli expressing chimeric polyhydroxyalkanoate synthase, overview. Incorporate the amino acid-derived 2-hydroxyalkanoate (2HA) units using PhaCAR and the 2HA-CoA-supplying enzymes lactate dehydrogenase (LdhA) and CoA transferase (HadA). Cells harboring the genes for PhaCAR, LdhA, and HadA, as well as for the 3HB-CoA-supplying enzymes beta-ketothiolase and acetoacetyl-CoA reductase, are cultivated with supplementation of four hydrophobic amino acids, i.e. leucine, valine, isoleucine, and phenylalanine, in the medium. No hydrophobic amino acid-derived monomers are incorporated into the polymer, which is most likely because of the strict substrate specificity of PhaCAR, except for P(2HB-co-3HB) which is produced with Val supplementation. The copolymer is likely P(2HB-beta-3HB) based on proton nuclear magnetic resonance analysis. Dual supplementation with Thr and Val shows synergy on the 2HB fraction of the polymer. Valine supplementation promotes the 2HB synthesis likely by inhibiting the metabolism of 2-oxobutyrate into Ile and/or activating Thr dehydratase. PhaCAR spontaneously synthesizes poly(2HB-block-3-hydroxybutyrate) [P(2HB-beta-3HB)] from the mixture of 2HB and 3HB supplemented in the medium. Poly(2-hydroxybutyrate-block-3-hydroxybutyrate) [P(2HA-beta-3HB)] biosynthesis pathways from threonine in engineered Escherichia coli and proposed role of valine, overview
additional information
establishment of Escherichia coli as a microbial secretion platform for 3-hydroxybutyrate oligomer and its end-capped forms using chain transfer reaction-mediated polyhydroxyalkanoate synthases, overview
additional information
-
mutation of Phe333 may directly impact the geometry of the catalytic Asp447 in the dimer. Since Phe333 and His448 are highly conserved in class I and II PhaC, it is highly possible that this architecture is shared among synthases from different classes
additional information
-
the enzyme is used for in vitro synthesis of polyhydroxyalkanoates on a hydrophobic support, i.e. highly oriented pyrolytic graphite. Using PhaECAv and 3-hydroxyoctanoyl-CoA at room temperature, a poly(3-hydroxyoctanoate) [P(3HO)] film is formed on the hydrophobic support with a thickness of a few nanometers, as revealed by atomic force microscopy
additional information
establishment of Escherichia coli as a microbial secretion platform for 3-hydroxybutyrate oligomer and its end-capped forms using chain transfer reaction-mediated polyhydroxyalkanoate synthases, overview
additional information
-
deletion of 13 amino acids from the C-terminus greatly affects the catalytic activity of the enzyme, retaining 1.1-7.4% of the total activity
additional information
construction of enzyme hybrids of PhaC from Bacillus megaterium and Bacillus cereus, i.e. PhaRBmCYB4 and PhaRYB4CBm. The molecular weight of P(3HB) synthesized by PhaRCYB4 decreased with increasing culture time and temperature, time-dependent behavior is observed for hybrid synthase PhaRBmCYB4, but not for PhaRYB4CBm, thus the molecular weight change is caused by the PhaCYB4 subunit
additional information
-
construction of enzyme hybrids of PhaC from Bacillus megaterium and Bacillus cereus, i.e. PhaRBmCYB4 and PhaRYB4CBm. The molecular weight of P(3HB) synthesized by PhaRCYB4 decreased with increasing culture time and temperature, time-dependent behavior is observed for hybrid synthase PhaRBmCYB4, but not for PhaRYB4CBm, thus the molecular weight change is caused by the PhaCYB4 subunit
additional information
establishment of Escherichia coli as a microbial secretion platform for 3-hydroxybutyrate oligomer and its end-capped forms using chain transfer reaction-mediated polyhydroxyalkanoate synthases, overview
additional information
-
construction of enzyme hybrids of PhaC from Bacillus megaterium and Bacillus cereus, i.e. PhaRBmCYB4 and PhaRYB4CBm. The molecular weight of P(3HB) synthesized by PhaRCYB4 decreased with increasing culture time and temperature, time-dependent behavior is observed for hybrid synthase PhaRBmCYB4, but not for PhaRYB4CBm, thus the molecular weight change is caused by the PhaCYB4 subunit
-
additional information
establishment of Escherichia coli as a microbial secretion platform for 3-hydroxybutyrate oligomer and its end-capped forms using chain transfer reaction-mediated polyhydroxyalkanoate synthases, overview
additional information
mutation of Phe333 may directly impact the geometry of the catalytic Asp447 in the dimer. Since Phe333 and His448 are highly conserved in class I and II PhaC, it is highly possible that this architecture is shared among synthases from different classes. Beneficial mutations displayed on PhaCCs-CAT, structure, overview
additional information
A0A1E8EW93; A0A1E8EW64
anaerobic production of the biopolymer poly(3-hydroxybutyrate) (PHB) and the monomer 3-hydroxybutyrate (3-HB) is achieved using recombinant clostridial acetogens supplied with syn-(thesis) gas as the sole carbon and energy source. 3-HB production is successfully accomplished by a synthetic pathway containing the genes thlA (encoding thiolase A), ctfA/B (encoding CoA-transferase A/B), and bdhA (encoding (R)-3-hydroxybutyrate dehydrogenase). The respective recombinant Clostridium coskatii [p83_tcb] strain produces autotrophically and heterotrophically 3-HB. As a proof of concept, production of PHB is achieved using recombinant Clostridium coskatii and Clostridium ljungdahlii strains expressing a synthetic PHB pathway containing the genes thlA (encoding thiolase A), hbd (encoding 3-hydroxybutyryl-CoA dehydrogenase), crt (encoding crotonase), phaJ (encoding (R)-enoyl-CoA hydratase), and phaEC (encoding PHA synthase). The strain Clostridium coskatii [p83_PHB_Scaceti] synthesizes heterotrophically 3.4% PHB per cell dry weight (CDW) and autotrophically 1.12% PHB per CDW
additional information
-
anaerobic production of the biopolymer poly(3-hydroxybutyrate) (PHB) and the monomer 3-hydroxybutyrate (3-HB) is achieved using recombinant clostridial acetogens supplied with syn-(thesis) gas as the sole carbon and energy source. 3-HB production is successfully accomplished by a synthetic pathway containing the genes thlA (encoding thiolase A), ctfA/B (encoding CoA-transferase A/B), and bdhA (encoding (R)-3-hydroxybutyrate dehydrogenase). The respective recombinant Clostridium coskatii [p83_tcb] strain produces autotrophically and heterotrophically 3-HB. As a proof of concept, production of PHB is achieved using recombinant Clostridium coskatii and Clostridium ljungdahlii strains expressing a synthetic PHB pathway containing the genes thlA (encoding thiolase A), hbd (encoding 3-hydroxybutyryl-CoA dehydrogenase), crt (encoding crotonase), phaJ (encoding (R)-enoyl-CoA hydratase), and phaEC (encoding PHA synthase). The strain Clostridium coskatii [p83_PHB_Scaceti] synthesizes heterotrophically 3.4% PHB per cell dry weight (CDW) and autotrophically 1.12% PHB per CDW
-
additional information
-
deleting the first 60 or 78 amino acid residues results in approximately 60% PHB accumulation, similar to that of the recombinant harboring wild-type phbCRe gene, while negligible, polyhydroxybutyrate is accumulated in the recombinant harboring the plasmid encoding PhbCRe with a deletion of N-terminal 88- or 98-amino acid residues. Polyhydroxybutyrate polymerized by mutant PhbCRe with a deletion of N-terminal 78 amino acid residues shows much higher molecular weight compared with that of the wild-type. Polyhydroxybutyrate synthase from Ralstonia eutropha with a deletion on N-terminal 88 amino acid residues shows a significant reduced activity, as reflected by only 1.5% polyhydroxybutyrate accumulation compared with the wild type which produces 58.4% polyhydroxybutyrate of the cell dry weight
additional information
-
fusion proteins composed of an N-terminal class II PHA synthase region (PhaCPa from Pseudomonas aeruginosa) and a C-terminal class I PHA synthase region (PhaCRe from Ralstonia eutropha) are constructed
additional information
engineering of a chimeric polyhydroxyalkanoate (PHA) synthase PhaCAR is composed of N-terminal portion of Aeromonas caviae PHA synthase and C-terminal portion of Ralstonia eutropha (Cupriavidus necator) PHA synthase. PhaCAR has a unique and useful capacity to synthesize the block PHA copolymer poly(2-hydroxybutyrate-block-3-hydroxybutyrate) [P(2HB-beta-3HB)] in engineered Escherichia coli from exogenous 2HB and 3HB. Synergy of valine and threonine supplementation on poly(2-hydroxybutyrate-block-3-hydroxybutyrate) synthesis in engineered Escherichia coli expressing chimeric polyhydroxyalkanoate synthase, overview. Incorporate the amino acid-derived 2-hydroxyalkanoate (2HA) units using PhaCAR and the 2HA-CoA-supplying enzymes lactate dehydrogenase (LdhA) and CoA transferase (HadA). Cells harboring the genes for PhaCAR, LdhA, and HadA, as well as for the 3HB-CoA-supplying enzymes beta-ketothiolase and acetoacetyl-CoA reductase, are cultivated with supplementation of four hydrophobic amino acids, i.e. leucine, valine, isoleucine, and phenylalanine, in the medium. No hydrophobic amino acid-derived monomers are incorporated into the polymer, which is most likely because of the strict substrate specificity of PhaCAR, except for P(2HB-co-3HB) which is produced with Val supplementation. The copolymer is likely P(2HB-beta-3HB) based on proton nuclear magnetic resonance analysis. Dual supplementation with Thr and Val shows synergy on the 2HB fraction of the polymer. Val supplementation promotes the 2HB synthesis likely by inhibiting the metabolism of 2-oxobutyrate into Ile and/or activating Thr dehydratase. PhaCAR spontaneously synthesizes poly(2HB-block-3-hydroxybutyrate) [P(2HB-beta-3HB)] from the mixture of 2HB and 3HB supplemented in the medium. Poly(2-hydroxybutyrate-block-3-hydroxybutyrate) [P(2HA-beta-3HB)] biosynthesis pathways from threonine in engineered Escherichia coli and proposed role of valine, overview
additional information
-
engineering of a chimeric polyhydroxyalkanoate (PHA) synthase PhaCAR is composed of N-terminal portion of Aeromonas caviae PHA synthase and C-terminal portion of Ralstonia eutropha (Cupriavidus necator) PHA synthase. PhaCAR has a unique and useful capacity to synthesize the block PHA copolymer poly(2-hydroxybutyrate-block-3-hydroxybutyrate) [P(2HB-beta-3HB)] in engineered Escherichia coli from exogenous 2HB and 3HB. Synergy of valine and threonine supplementation on poly(2-hydroxybutyrate-block-3-hydroxybutyrate) synthesis in engineered Escherichia coli expressing chimeric polyhydroxyalkanoate synthase, overview. Incorporate the amino acid-derived 2-hydroxyalkanoate (2HA) units using PhaCAR and the 2HA-CoA-supplying enzymes lactate dehydrogenase (LdhA) and CoA transferase (HadA). Cells harboring the genes for PhaCAR, LdhA, and HadA, as well as for the 3HB-CoA-supplying enzymes beta-ketothiolase and acetoacetyl-CoA reductase, are cultivated with supplementation of four hydrophobic amino acids, i.e. leucine, valine, isoleucine, and phenylalanine, in the medium. No hydrophobic amino acid-derived monomers are incorporated into the polymer, which is most likely because of the strict substrate specificity of PhaCAR, except for P(2HB-co-3HB) which is produced with Val supplementation. The copolymer is likely P(2HB-beta-3HB) based on proton nuclear magnetic resonance analysis. Dual supplementation with Thr and Val shows synergy on the 2HB fraction of the polymer. Val supplementation promotes the 2HB synthesis likely by inhibiting the metabolism of 2-oxobutyrate into Ile and/or activating Thr dehydratase. PhaCAR spontaneously synthesizes poly(2HB-block-3-hydroxybutyrate) [P(2HB-beta-3HB)] from the mixture of 2HB and 3HB supplemented in the medium. Poly(2-hydroxybutyrate-block-3-hydroxybutyrate) [P(2HA-beta-3HB)] biosynthesis pathways from threonine in engineered Escherichia coli and proposed role of valine, overview
additional information
establishment of Escherichia coli as a microbial secretion platform for 3-hydroxybutyrate oligomer and its end-capped forms using chain transfer reaction-mediated polyhydroxyalkanoate synthases, overview
additional information
mutation of Phe333 may directly impact the geometry of the catalytic Asp447 in the dimer. Since Phe333 and His448 are highly conserved in class I and II PhaC, it is highly possible that this architecture is shared among synthases from different classes
additional information
-
mutation of Phe333 may directly impact the geometry of the catalytic Asp447 in the dimer. Since Phe333 and His448 are highly conserved in class I and II PhaC, it is highly possible that this architecture is shared among synthases from different classes
additional information
translationally fusing a target protein to PHA synthase using a self-cleaving intein as linker, intracellular production of PHA beads is achieved. Upon isolation of respective PHA beads the soluble pure target protein is released by a simple pH shift to pH 6.0. The utility of this approach is exemplified by producing six target proteins, including Aequorea victoria green fluorescent protein (GFP), Mycobacterium tuberculosis vaccine candidate Rv1626, the immunoglobulin G (IgG) binding ZZ domain of protein A derived from Staphylococcus aureus, human tumor necrosis factor alpha (TNFalpha), human granulocyte colony-stimulating factor (G-CSF), and human interferon alpha 2beta (IFNalpha2beta)
additional information
-
mutation of Phe333 may directly impact the geometry of the catalytic Asp447 in the dimer. Since Phe333 and His448 are highly conserved in class I and II PhaC, it is highly possible that this architecture is shared among synthases from different classes
-
additional information
-
establishment of Escherichia coli as a microbial secretion platform for 3-hydroxybutyrate oligomer and its end-capped forms using chain transfer reaction-mediated polyhydroxyalkanoate synthases, overview
-
additional information
-
engineering of a chimeric polyhydroxyalkanoate (PHA) synthase PhaCAR is composed of N-terminal portion of Aeromonas caviae PHA synthase and C-terminal portion of Ralstonia eutropha (Cupriavidus necator) PHA synthase. PhaCAR has a unique and useful capacity to synthesize the block PHA copolymer poly(2-hydroxybutyrate-block-3-hydroxybutyrate) [P(2HB-beta-3HB)] in engineered Escherichia coli from exogenous 2HB and 3HB. Synergy of valine and threonine supplementation on poly(2-hydroxybutyrate-block-3-hydroxybutyrate) synthesis in engineered Escherichia coli expressing chimeric polyhydroxyalkanoate synthase, overview. Incorporate the amino acid-derived 2-hydroxyalkanoate (2HA) units using PhaCAR and the 2HA-CoA-supplying enzymes lactate dehydrogenase (LdhA) and CoA transferase (HadA). Cells harboring the genes for PhaCAR, LdhA, and HadA, as well as for the 3HB-CoA-supplying enzymes beta-ketothiolase and acetoacetyl-CoA reductase, are cultivated with supplementation of four hydrophobic amino acids, i.e. leucine, valine, isoleucine, and phenylalanine, in the medium. No hydrophobic amino acid-derived monomers are incorporated into the polymer, which is most likely because of the strict substrate specificity of PhaCAR, except for P(2HB-co-3HB) which is produced with Val supplementation. The copolymer is likely P(2HB-beta-3HB) based on proton nuclear magnetic resonance analysis. Dual supplementation with Thr and Val shows synergy on the 2HB fraction of the polymer. Val supplementation promotes the 2HB synthesis likely by inhibiting the metabolism of 2-oxobutyrate into Ile and/or activating Thr dehydratase. PhaCAR spontaneously synthesizes poly(2HB-block-3-hydroxybutyrate) [P(2HB-beta-3HB)] from the mixture of 2HB and 3HB supplemented in the medium. Poly(2-hydroxybutyrate-block-3-hydroxybutyrate) [P(2HA-beta-3HB)] biosynthesis pathways from threonine in engineered Escherichia coli and proposed role of valine, overview
-
additional information
-
translationally fusing a target protein to PHA synthase using a self-cleaving intein as linker, intracellular production of PHA beads is achieved. Upon isolation of respective PHA beads the soluble pure target protein is released by a simple pH shift to pH 6.0. The utility of this approach is exemplified by producing six target proteins, including Aequorea victoria green fluorescent protein (GFP), Mycobacterium tuberculosis vaccine candidate Rv1626, the immunoglobulin G (IgG) binding ZZ domain of protein A derived from Staphylococcus aureus, human tumor necrosis factor alpha (TNFalpha), human granulocyte colony-stimulating factor (G-CSF), and human interferon alpha 2beta (IFNalpha2beta)
-
additional information
-
mutation of Phe333 may directly impact the geometry of the catalytic Asp447 in the dimer. Since Phe333 and His448 are highly conserved in class I and II PhaC, it is highly possible that this architecture is shared among synthases from different classes
-
additional information
-
establishment of Escherichia coli as a microbial secretion platform for 3-hydroxybutyrate oligomer and its end-capped forms using chain transfer reaction-mediated polyhydroxyalkanoate synthases, overview
-
additional information
-
engineering of a chimeric polyhydroxyalkanoate (PHA) synthase PhaCAR is composed of N-terminal portion of Aeromonas caviae PHA synthase and C-terminal portion of Ralstonia eutropha (Cupriavidus necator) PHA synthase. PhaCAR has a unique and useful capacity to synthesize the block PHA copolymer poly(2-hydroxybutyrate-block-3-hydroxybutyrate) [P(2HB-beta-3HB)] in engineered Escherichia coli from exogenous 2HB and 3HB. Synergy of valine and threonine supplementation on poly(2-hydroxybutyrate-block-3-hydroxybutyrate) synthesis in engineered Escherichia coli expressing chimeric polyhydroxyalkanoate synthase, overview. Incorporate the amino acid-derived 2-hydroxyalkanoate (2HA) units using PhaCAR and the 2HA-CoA-supplying enzymes lactate dehydrogenase (LdhA) and CoA transferase (HadA). Cells harboring the genes for PhaCAR, LdhA, and HadA, as well as for the 3HB-CoA-supplying enzymes beta-ketothiolase and acetoacetyl-CoA reductase, are cultivated with supplementation of four hydrophobic amino acids, i.e. leucine, valine, isoleucine, and phenylalanine, in the medium. No hydrophobic amino acid-derived monomers are incorporated into the polymer, which is most likely because of the strict substrate specificity of PhaCAR, except for P(2HB-co-3HB) which is produced with Val supplementation. The copolymer is likely P(2HB-beta-3HB) based on proton nuclear magnetic resonance analysis. Dual supplementation with Thr and Val shows synergy on the 2HB fraction of the polymer. Val supplementation promotes the 2HB synthesis likely by inhibiting the metabolism of 2-oxobutyrate into Ile and/or activating Thr dehydratase. PhaCAR spontaneously synthesizes poly(2HB-block-3-hydroxybutyrate) [P(2HB-beta-3HB)] from the mixture of 2HB and 3HB supplemented in the medium. Poly(2-hydroxybutyrate-block-3-hydroxybutyrate) [P(2HA-beta-3HB)] biosynthesis pathways from threonine in engineered Escherichia coli and proposed role of valine, overview
-
additional information
-
translationally fusing a target protein to PHA synthase using a self-cleaving intein as linker, intracellular production of PHA beads is achieved. Upon isolation of respective PHA beads the soluble pure target protein is released by a simple pH shift to pH 6.0. The utility of this approach is exemplified by producing six target proteins, including Aequorea victoria green fluorescent protein (GFP), Mycobacterium tuberculosis vaccine candidate Rv1626, the immunoglobulin G (IgG) binding ZZ domain of protein A derived from Staphylococcus aureus, human tumor necrosis factor alpha (TNFalpha), human granulocyte colony-stimulating factor (G-CSF), and human interferon alpha 2beta (IFNalpha2beta)
-
additional information
-
mutation of Phe333 may directly impact the geometry of the catalytic Asp447 in the dimer. Since Phe333 and His448 are highly conserved in class I and II PhaC, it is highly possible that this architecture is shared among synthases from different classes
-
additional information
-
establishment of Escherichia coli as a microbial secretion platform for 3-hydroxybutyrate oligomer and its end-capped forms using chain transfer reaction-mediated polyhydroxyalkanoate synthases, overview
-
additional information
-
engineering of a chimeric polyhydroxyalkanoate (PHA) synthase PhaCAR is composed of N-terminal portion of Aeromonas caviae PHA synthase and C-terminal portion of Ralstonia eutropha (Cupriavidus necator) PHA synthase. PhaCAR has a unique and useful capacity to synthesize the block PHA copolymer poly(2-hydroxybutyrate-block-3-hydroxybutyrate) [P(2HB-beta-3HB)] in engineered Escherichia coli from exogenous 2HB and 3HB. Synergy of valine and threonine supplementation on poly(2-hydroxybutyrate-block-3-hydroxybutyrate) synthesis in engineered Escherichia coli expressing chimeric polyhydroxyalkanoate synthase, overview. Incorporate the amino acid-derived 2-hydroxyalkanoate (2HA) units using PhaCAR and the 2HA-CoA-supplying enzymes lactate dehydrogenase (LdhA) and CoA transferase (HadA). Cells harboring the genes for PhaCAR, LdhA, and HadA, as well as for the 3HB-CoA-supplying enzymes beta-ketothiolase and acetoacetyl-CoA reductase, are cultivated with supplementation of four hydrophobic amino acids, i.e. leucine, valine, isoleucine, and phenylalanine, in the medium. No hydrophobic amino acid-derived monomers are incorporated into the polymer, which is most likely because of the strict substrate specificity of PhaCAR, except for P(2HB-co-3HB) which is produced with Val supplementation. The copolymer is likely P(2HB-beta-3HB) based on proton nuclear magnetic resonance analysis. Dual supplementation with Thr and Val shows synergy on the 2HB fraction of the polymer. Val supplementation promotes the 2HB synthesis likely by inhibiting the metabolism of 2-oxobutyrate into Ile and/or activating Thr dehydratase. PhaCAR spontaneously synthesizes poly(2HB-block-3-hydroxybutyrate) [P(2HB-beta-3HB)] from the mixture of 2HB and 3HB supplemented in the medium. Poly(2-hydroxybutyrate-block-3-hydroxybutyrate) [P(2HA-beta-3HB)] biosynthesis pathways from threonine in engineered Escherichia coli and proposed role of valine, overview
-
additional information
-
translationally fusing a target protein to PHA synthase using a self-cleaving intein as linker, intracellular production of PHA beads is achieved. Upon isolation of respective PHA beads the soluble pure target protein is released by a simple pH shift to pH 6.0. The utility of this approach is exemplified by producing six target proteins, including Aequorea victoria green fluorescent protein (GFP), Mycobacterium tuberculosis vaccine candidate Rv1626, the immunoglobulin G (IgG) binding ZZ domain of protein A derived from Staphylococcus aureus, human tumor necrosis factor alpha (TNFalpha), human granulocyte colony-stimulating factor (G-CSF), and human interferon alpha 2beta (IFNalpha2beta)
-
additional information
establishment of Escherichia coli as a microbial secretion platform for 3-hydroxybutyrate oligomer and its end-capped forms using chain transfer reaction-mediated polyhydroxyalkanoate synthases, overview
additional information
construction of enzyme hybrids of PhaC from Bacillus megaterium and Bacillus cereus, i.e. PhaRBmCYB4 and PhaRYB4CBm. The molecular weight of P(3HB) synthesized by PhaRCYB4 decreased with increasing culture time and temperature, time-dependent behavior is observed for hybrid synthase PhaRBmCYB4, but not for PhaRYB4CBm, thus the molecular weight change is caused by the PhaCYB4 subunit
additional information
-
construction of enzyme hybrids of PhaC from Bacillus megaterium and Bacillus cereus, i.e. PhaRBmCYB4 and PhaRYB4CBm. The molecular weight of P(3HB) synthesized by PhaRCYB4 decreased with increasing culture time and temperature, time-dependent behavior is observed for hybrid synthase PhaRBmCYB4, but not for PhaRYB4CBm, thus the molecular weight change is caused by the PhaCYB4 subunit
additional information
establishment of Escherichia coli as a microbial secretion platform for 3-hydroxybutyrate oligomer and its end-capped forms using chain transfer reaction-mediated polyhydroxyalkanoate synthases, overview
additional information
-
construction of enzyme hybrids of PhaC from Bacillus megaterium and Bacillus cereus, i.e. PhaRBmCYB4 and PhaRYB4CBm. The molecular weight of P(3HB) synthesized by PhaRCYB4 decreased with increasing culture time and temperature, time-dependent behavior is observed for hybrid synthase PhaRBmCYB4, but not for PhaRYB4CBm, thus the molecular weight change is caused by the PhaCYB4 subunit
-
additional information
-
the enzyme is used for in vitro synthesis of polyhydroxyalkanoates on a hydrophobic support, i.e. highly oriented pyrolytic graphite. Using PhaC1Pp and 3-hydroxyoctanoyl-CoA at room temperature, a poly(3-hydroxyoctanoate) [P(3HO)] film is formed on the hydrophobic support with a thickness of a few nanometers, as revealed by atomic force microscopy
additional information
-
sequences derived from SNARE domains efficiently target and integrate the poly-3-hydroxyalkanoate synthase from Pseudomonas putida CA-3 to the membrane of secretory vesicles in Saccharomyces cerevisiae
additional information
-
sequences derived from SNARE domains efficiently target and integrate the poly-3-hydroxyalkanoate synthase from Pseudomonas putida CA-3 to the membrane of secretory vesicles in Saccharomyces cerevisiae
-
additional information
the double mutations of Ser325X and Gln481X show further increments in the production of P(3HB), up by 340 to 400fold higher than the wild-type. Mutation of Phe333 may directly impact the geometry of the catalytic Asp447 in the dimer. Since Phe333 and His448 are highly conserved in class I and II PhaC, it is highly possible that this architecture is shared among synthases from different classes
additional information
-
recombinant phaC-deficient Cupriavidus necator expressing the enzyme is able to accumulate PHA homopolymers and copolymers including poly(3-hydroxybutyrate) [P(3HB)], poly(3-hydroxybutyrate-co-3-hydroxyvalerate) [P(3HB-co-3HV)], poly(3-hydroxybutyrate-co-5-hydroxyvalerate) [P(3HB-co-5HV)], poly(3-hydroxybutyrate-co-4-hydroxybutyrate) [P(3HB-co-4HB)], poly(3-hydroxybutyrate-co-3-hydroxy-4-methylvalerate) [P(3HB-co-3H4MV)], and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) [P(3HB-co-3HHx)], when suitable precursors are provided